Company / Operating Income per Share
Inhibrx Biosciences, Inc. Operating Income per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$9.33
FY2025
5-year range
-$18.60 / -$4.63
FY2023-FY2025
Trend
-101.6%
vs FY2024
Sector context
#192 of 201
Health Care
What the data says
Among 201 Health Care companies, Inhibrx Biosciences, Inc. is in the bottom 4% for operating income per share. Improved from $-18.60 to $-9.33 over the past 2 years.
Based on SEC 10-K filings.
-9.33 in FY2025.
Improved from $-18.60 to $-9.33 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 201This company -$9.33 Sector average -$28.56
▼
+67.3% above sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 101.6% year-over-year.
- Ranks #192 out of 201 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -3.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$9.33 | -101.6% |
| FY2024 | -$4.63 | +75.1% |
| FY2023 | -$18.60 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026